Isla P. Garraway

Urology
10833 Le Conte Ave
Los Angeles, CA 90095

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications

Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-Prostate.

Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-Prostate.

Journal: JCO precision oncology
Published: July 15, 2026

Prostate-Specific Antigen Screening Patterns and Metastatic Prostate Cancer in US Veterans.

Prostate-Specific Antigen Screening Patterns and Metastatic Prostate Cancer in US Veterans.

Journal: JAMA network open
Published: July 06, 2026

Equity and Cancer Survival Among Veterans Health Administration Patients: A Systematic Review and Meta-Analysis.

Equity and Cancer Survival Among Veterans Health Administration Patients: A Systematic Review and Meta-Analysis.

Journal: JAMA network open
Published: July 02, 2026

Development and External Validation of a Machine Learning-Based Risk Classification Score for Prostate Cancer-Specific Cardiovascular Risk.

Development and External Validation of a Machine Learning-Based Risk Classification Score for Prostate Cancer-Specific Cardiovascular Risk.

Journal: JCO oncology practice
Published: May 29, 2026

Germline polygenic score for prostate cancer aggressiveness.

Germline polygenic score for prostate cancer aggressiveness.

Journal: medRxiv : the preprint server for health sciences
Published: May 18, 2026

Interference of clonal hematopoiesis in cfDNA liquid biopsy testing and identification of actionable alterations in large diverse cohort of US veterans.

Interference of clonal hematopoiesis in cfDNA liquid biopsy testing and identification of actionable alterations in large diverse cohort of US veterans.

Journal: The oncologist
Published: March 06, 2026

A Comparison of Prostate Cancer Incidence and Mortality Rates in the Veterans Affairs Healthcare system and the Surveillance, Epidemiology, and End Results Program.

A Comparison of Prostate Cancer Incidence and Mortality Rates in the Veterans Affairs Healthcare system and the Surveillance, Epidemiology, and End Results Program.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: February 10, 2026

Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active Surveillance.

Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active Surveillance.

Journal: JAMA oncology
Published: November 20, 2025

Prognostic Significance of RB1 Alterations on Outcomes in Metastatic Prostate Cancer.

Prognostic Significance of RB1 Alterations on Outcomes in Metastatic Prostate Cancer.

Journal: JCO precision oncology
Published: September 19, 2025

Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patients With Prostate Cancer.

Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patients With Prostate Cancer.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: September 09, 2025

Tumor suppressor genes, treatments, and survival in US veterans with prostate cancer.

Tumor suppressor genes, treatments, and survival in US veterans with prostate cancer.

Journal: The oncologist
Published: September 01, 2025

Tumor suppressor genes, treatments, and survival in US veterans with prostate cancer.

Tumor suppressor genes, treatments, and survival in US veterans with prostate cancer.

Journal: The oncologist
Published: September 01, 2025
Showing 1-12 of 74

Last Updated: 09/26/2026